With an estimated global prevalence of 25%, Non-alcoholic fatty liver disease (NAFLD) is a global public health epidemic that is not receiving enough attention. The first step to taking a comprehensive public health response to NAFLD is to review the relevant policies and guidelines in place. For this reason, EASL International Liver Foundation (EILF) will launch the EILF NAFLD policy review later this month to determine to what extent governments and key stakeholders like medical associations and patient groups are responding to NAFLD and its complications such as diabetes and HCC.
This project is being led by Professors Jeffrey Lazarus (IS Global, University of Barcelona), Professor Quentin Anstee (Newcastle University) and Professor Helena Cortez-Pinto (University Hospital Lisbon). Preliminary results are expected to be announced at the EASL International Liver Congress in April, 2018.